Fusion Antibodies (FAB) Insider Trading & Ownership GBX 14 0.00 (0.00%) As of 08/22/2025 11:50 AM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Fusion Antibodies (LON:FAB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.39%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)£15.79KNumber OfInsiders Selling(Last 12 Months)0 Get FAB Insider Trade Alerts Want to know when executives and insiders are buying or selling Fusion Antibodies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address FAB Insider Buying and Selling by Quarter Fusion Antibodies Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/6/2025Adrian KinkaidInsiderBuy100,000GBX 6£6,00010/16/2024Adrian KinkaidInsiderBuy83,728GBX 4£3,349.129/9/2024Richard John BuickInsiderBuy94,825GBX 3£2,844.759/4/2024Adrian KinkaidInsiderBuy120,000GBX 3£3,600 (Data available from 1/1/2013 forward) FAB Insider Trading Activity - Frequently Asked Questions Who is on Fusion Antibodies' Insider Roster? The list of insiders at Fusion Antibodies includes Adrian Kinkaid, Richard John Buick, Simon Gordon Douglas, and Sonya Maria Ferguson. Learn more on insiders at FAB. What percentage of Fusion Antibodies stock is owned by insiders? 11.39% of Fusion Antibodies stock is owned by insiders. Learn more on FAB's insider holdings. Which Fusion Antibodies insiders have been buying company stock? The following insiders have purchased FAB shares in the last 24 months: Adrian Kinkaid (£12,949.12), Richard John Buick (£2,844.75), and Simon Gordon Douglas (£9,528.25). How much insider buying is happening at Fusion Antibodies? Insiders have purchased a total of 649,118 FAB shares in the last 24 months for a total of £25,322.12 bought. Fusion Antibodies Key ExecutivesDr. Adrian Robert Kinkaid Ph.D. (Age 57)CEO & Director Compensation: $183.49kDr. Richard John Buick Ph.D. (Age 48)Chief Scientific Officer & Director Compensation: $127kProf. Jim JohnstonFounderMr. Stephen Barry Smyth (Age 50)Company Secretary, Interim CFO & Director Ms. Nicola HamiltonOperations ManagerDr. Paul Gerard Kerr (Age 51)Consultant Compensation: $180.38k More Insider Trading Tools from MarketBeat Related Companies SAR Insider Transactions AREC Insider Transactions POLB Insider Transactions IXI Insider Transactions OBD Insider Transactions ROQ Insider Transactions ONC Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying This page (LON:FAB) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Antibodies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fusion Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access